Pomona’s GRE1 Receives EMA Orphan Drug Designation for PML

Pomona is pleased to announce that GRE1, an investigational therapeutic candidate for Progressive Multifocal Leukoencephalopathy (PML), a rare and life-threatening neurological disease caused by the reactivation of the JC virus (JCV), has received Orphan Drug Designation (ODD) from the European Medicines Agency (EMA). This designation represents an important mi